Papers - SAITO MANABU
-
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.（共著）
Fujii A, Yasui-Furukori N, Nakagami T, Niioka T, Saito M, Sato Y, Kaneko S.
Drug Design, Development and Therapy. 2 139 - 144 2009.2
-
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.
Fujii A, Yasui-Furukori N, Nakagami T, Niioka T, Saito M, Sato Y, Kaneko S
Drug design, development and therapy 2 139 - 144 2009.2
-
Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.（共著）
Yasui-Furukori N, Sato Y, Furukori H, Saito M, Nakagami T, Kaneko S.
The Journal of Clinical Psychiatry. 70 ( 1 ) 95 - 100 2009.1
-
Glucose Metabolism in Japanese Schizophrenia Patients Treated With Risperidone or Olanzapine
Norio Yasui-Furukori, Yasushi Sato, Hanako Furukori, Manabu Saito, Taku Nakagami, Sunao Kaneko
JOURNAL OF CLINICAL PSYCHIATRY 70 ( 1 ) 95 - 100 2009.1
-
Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals.(共著)
Tsuchimine S, Yasui-Furukori N, Kaneda A, Saito M, Nakagami T, Sato K, Kaneko S.
Progress in Neuro-psychopharmacology and Biological Psychiatry. 32 ( 8 ) 1932 - 1935 2008.12
-
Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals.
Shoko Tsuchimine, Norio Yasui-Furukori, Ayako Kaneda, Manabu Saito, Taku Nakagami, Kimihiko Sato, Sunao Kaneko
Progress in neuro-psychopharmacology & biological psychiatry 32 ( 8 ) 1932 - 5 2008.12
-
Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.(共著)
Yasui-Furukori N, Saito M, Tsuchimine S, Nakagami T, Sato Y, Sugawara N, Kaneko S.
Progress in Neuro-psychopharmacology and Biological Psychiatry. 32 ( 6 ) 1491 - 1495 2008.8
-
Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
Norio Yasui-Furukori, Manabu Saito, Shoko Tsuchimine, Taku Nakagami, Yasushi Sato, Norio Sugawara, Sunao Kaneko
Progress in neuro-psychopharmacology & biological psychiatry 32 ( 6 ) 1491 - 5 2008.8
-
Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese.
Norio Yasui-Furukori, Ayako Kaneda, Kumiko Iwashima, Manabu Saito, Taku Nakagami, Shoko Tsuchimine, Sunao Kaneko
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 144B ( 6 ) 724 - 7 2007.9
-
29-P1-144 躁患者におけるバルプロ酸徐放性錠剤の母集団薬物動態解析(TDM/薬物動態,社会の期待に応える医療薬学を)
新岡 丈典, 古郡 規雄, 戸清 達郎, 杉山 恵理花, 斉藤 まなぶ, 佐藤 靖, 兼子 直, 佐藤 均, 早狩 誠
日本医療薬学会年会講演要旨集 17 ( 0 ) 240 2007.9
-
Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese.(共著)
Yasui-Furukori N, Kaneda A, Iwashima K, Saito M, Nakagami T, Tsuchimine S, Kaneko S.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 144B ( 6 ) 724 - 727 2007.9
-
Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.(共著)
Yasui-Furukori N, Tsuchimine S, Saito M, Nakagami T, Sato Y, Kaneko S.
Progress in Neuro-psychopharmacology and Biological Psychiatry. 31 ( 6 ) 1230 - 1234 2007.8
-
Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.
Norio Yasui-Furukori, Shoko Tsuchimine, Manabu Saito, Taku Nakagami, Yasushi Sato, Sunao Kaneko
Progress in neuro-psychopharmacology & biological psychiatry 31 ( 6 ) 1230 - 4 2007.8
-
No association between CYP2D6 polymorphisms and personality trait in Japanese.（共著）
Iwashima K, Yasui-Furukori N, Kaneda A, Saito M, Nakagami T, Sato Y, Kaneko S.
British Journal of Clinical Pharmacology 64 ( 1 ) 96 - 99 2007.7
-
No association between CYP2D6 polymorphisms and personality trait in Japanese
Kumiko Iwashima, Norio Yasui-Furukori, Ayako Kaneda, Manabu Saito, Taku Nakagami, Yasushi Sato, Sunao Kaneko
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 64 ( 1 ) 96 - 99 2007.7
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.(共著)
Yasui-Furukori N, Saito M, Nakagami T, Niioka T, Sato Y, Fujii A, Kaneko S.
Psychiatry and Clinical Neuroscience 61 ( 3 ) 308 - 312 2007.6
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations
Norio Yasui-Furukori, Manabu Saito, Taku Nakagami, Takenori Niioka, Yasushi Sato, Akira Fujii, Sunao Kaneko
PSYCHIATRY AND CLINICAL NEUROSCIENCES 61 ( 3 ) 308 - 312 2007.6
-
Dose-dependent interaction of paroxetine with riperidone in schizophrenic patients.
Saito M. Yasui-Furukori N, Nakagami T, Furukori H, Kaneko S
Journal of Clinical Psychopharmacology 25 527 - 532 2007.3
-
Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.（共著）
Yasui-Furukori N, Saito M, Niioka T, Inoue Y, Sato Y, Kaneko S.
Therapeutic Drug Monitoring 29 ( 1 ) 45 - 48 2007.2
-
Effect of itraconazole on pharmacokinetics of paroxetine: The role of gut transporters
Norio Yasui-Furukori, Manabu Saito, Takenori Niioka, Yoshimasa Inoue, Yasushi Sato, Sunao Kaneko
THERAPEUTIC DRUG MONITORING 29 ( 1 ) 45 - 48 2007.2